Immuneering Historical Balance Sheet
| IMRX Stock | USD 2.09 0.04 1.88% |
Trend analysis of Immuneering Corp balance sheet accounts such as Other Current Liabilities of 3.3 M or Total Current Liabilities of 5.3 M provides information on Immuneering Corp's total assets, liabilities, and equity, which is the actual value of Immuneering Corp to its prevalent stockholders. By breaking down trends over time using Immuneering Corp balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Immuneering Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Immuneering Corp is a good buy for the upcoming year.
Immuneering Corp Inventory |
|
Immuneering |
About Immuneering Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Immuneering Corp at a specified time, usually calculated after every quarter, six months, or one year. Immuneering Corp Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Immuneering Corp and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Immuneering currently owns. An asset can also be divided into two categories, current and non-current.
Immuneering Corp Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Immuneering Corp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Immuneering Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Immuneering Corp balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Immuneering Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Retained Earnings Total Equity
The portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt.Most accounts from Immuneering Corp's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Immuneering Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuneering Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.At this time, Immuneering Corp's Short and Long Term Debt Total is fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.1 M in 2024, whereas Total Assets are likely to drop slightly above 97.7 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 5.4M | 4.8M | 4.5M | 5.1M | Total Assets | 166.7M | 122.4M | 102.6M | 97.7M |
Immuneering Corp balance sheet Correlations
Click cells to compare fundamentals
Immuneering Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.